A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Lisa M. DeFrancesco.

Business address: C/O Intercept Pharmaceuticals, Inc., 10 Hudson Yards, Floor 37, New York, NY, 10001
Top holdings (ownership): ICPT and LXRX

Get insider transactions for this reporting owner

Lisa M. DeFrancesco has filed 8 SEC EDGAR filings since 17 Feb 2021

Recent SEC filings for Lisa M. DeFrancesco including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	PRIMARY DOCUMENT	17 Feb 2026	12 Feb 2026	000-30111
4	Open 4 document	View SEC filing for 4	PRIMARY DOCUMENT	03 Mar 2025	28 Feb 2025	000-30111
4	Open 4 document	View SEC filing for 4	PRIMARY DOCUMENT	18 Feb 2025	13 Feb 2025	000-30111
3	Open 3 document	View SEC filing for 3	PRIMARY DOCUMENT	07 Oct 2024	02 Oct 2024	000-30111
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	04 Jan 2022	31 Dec 2021	001-35668
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	04 Oct 2021	30 Sep 2021	001-35668
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	03 Sep 2021	01 Sep 2021	001-35668
3	Open 3 document	View SEC filing for 3	OWNERSHIP DOCUMENT	17 Feb 2021	15 Feb 2021	001-35668

Lisa M. DeFrancesco files with the SEC under CIK 0001846325. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.